Asherson, P. ( 2005). Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Review of Neurotherapeutics , 5, 525-539.
2.
Atmaca, M., Ozler, S., Topuz, M., & Goldstein, S. ( 2009). Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder. Journal of Attention Disorders, 13, 197-198.
3.
Biederman, J., Klein, R.G., Pine, D.S., & Klein, D.F. ( 1998). Resolved: Mania is mistaken for ADHD in prepubertal children . Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1091-1096.
4.
Blader, J.C., & Carlson, G.A. ( 2007). Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004. Biological Psychiatry, 62, 107-114.
5.
Hegerl, U., Himmerich, H., Engmann, B., & Hensch, T. ( 2010). Mania and attention-deficit/hyperactivity disorder: Common symptomatology, common pathophysiology and common treatment?Current Opinion in Psychiatry, 23, 1-7.
6.
Hegerl, U., Sander, C., Olbrich, S., & Schönknecht, P. (2009). Are psychostimulants a treatment option in mania?Pharmacopsychiatry, 42, 169-174.
7.
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A.B., & Olfson, M. ( 2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry , 64, 1032-1039.
8.
Reimherr, F.W., Marchant, B.K., Strong, R.E., Hedges, D.W., Adler, L., Spencer, T.J., . . . Soni, P. ( 2005). Emotional dysregulation in adult ADHD and response to atomoxetine. Biological Psychiatry, 58, 125-131.
9.
Reimherr, F.W., Williams, E.D., Strong, R.E., Mestas, R., Soni, P., & Marchant, B.K. (2007). A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder . Journal of Clinical Psychiatry, 68, 93-101.
10.
Skirrow, C., McLoughlin, G., Kuntsi, J., & Asherson, P. ( 2009). Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Review of Neurotherapeutics, 9, 489-503.